Global Hospital-Acquired Pneumonia Prevention Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Hospital-Acquired Pneumonia Prevention Market
HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcare centers and increases the length of stay in ICU.

The global Hospital-Acquired Pneumonia Prevention market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Oral Care Kit accounting for % of the Hospital-Acquired Pneumonia Prevention global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Hospital-Acquired Pneumonia Prevention market size is valued at US$ million in 2021, while the North America and Europe Hospital-Acquired Pneumonia Prevention are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Hospital-Acquired Pneumonia Prevention landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital-Acquired Pneumonia Prevention market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital-Acquired Pneumonia Prevention market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital-Acquired Pneumonia Prevention market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital-Acquired Pneumonia Prevention market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Hospital-Acquired Pneumonia Prevention market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Hospital-Acquired Pneumonia Prevention Breakdown Data by Type

Oral Care Kit

Toothbrush

Swab

Moisturizer

Mouth Wash

Suction Tools

Hospital-Acquired Pneumonia Prevention Breakdown Data by Application

Hospitals

Rehabilitation Centers

Home Care Settings

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Halyard Health

Sage Products LLC

Intersurgical Ltd.

Medline Industries

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Oral Care Kit

1.2.3 Toothbrush

1.2.4 Swab

1.2.5 Moisturizer

1.2.6 Mouth Wash

1.2.7 Suction Tools

1.3 Market by Application

1.3.1 Global Hospital-Acquired Pneumonia Prevention Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospitals

1.3.3 Rehabilitation Centers

1.3.4 Home Care Settings

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Hospital-Acquired Pneumonia Prevention Market Perspective (2017-2028)

2.2 Hospital-Acquired Pneumonia Prevention Growth Trends by Region

2.2.1 Hospital-Acquired Pneumonia Prevention Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Hospital-Acquired Pneumonia Prevention Historic Market Size by Region (2017-2022)

2.2.3 Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Region (2023-2028)

2.3 Hospital-Acquired Pneumonia Prevention Market Dynamics

2.3.1 Hospital-Acquired Pneumonia Prevention Industry Trends

2.3.2 Hospital-Acquired Pneumonia Prevention Market Drivers

2.3.3 Hospital-Acquired Pneumonia Prevention Market Challenges

2.3.4 Hospital-Acquired Pneumonia Prevention Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Revenue

3.1.1 Global Top Hospital-Acquired Pneumonia Prevention Players by Revenue (2017-2022)

3.1.2 Global Hospital-Acquired Pneumonia Prevention Revenue Market Share by Players (2017-2022)

3.2 Global Hospital-Acquired Pneumonia Prevention Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hospital-Acquired Pneumonia Prevention Revenue

3.4 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio

3.4.1 Global Hospital-Acquired Pneumonia Prevention Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Pneumonia Prevention Revenue in 2021

3.5 Hospital-Acquired Pneumonia Prevention Key Players Head office and Area Served

3.6 Key Players Hospital-Acquired Pneumonia Prevention Product Solution and Service

3.7 Date of Enter into Hospital-Acquired Pneumonia Prevention Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital-Acquired Pneumonia Prevention Breakdown Data by Type

4.1 Global Hospital-Acquired Pneumonia Prevention Historic Market Size by Type (2017-2022)

4.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Type (2023-2028)

5 Hospital-Acquired Pneumonia Prevention Breakdown Data by Application

5.1 Global Hospital-Acquired Pneumonia Prevention Historic Market Size by Application (2017-2022)

5.2 Global Hospital-Acquired Pneumonia Prevention Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Hospital-Acquired Pneumonia Prevention Market Size (2017-2028)

6.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Type

6.2.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2017-2022)

6.2.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Type (2023-2028)

6.2.3 North America Hospital-Acquired Pneumonia Prevention Market Share by Type (2017-2028)

6.3 North America Hospital-Acquired Pneumonia Prevention Market Size by Application

6.3.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2017-2022)

6.3.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Application (2023-2028)

6.3.3 North America Hospital-Acquired Pneumonia Prevention Market Share by Application (2017-2028)

6.4 North America Hospital-Acquired Pneumonia Prevention Market Size by Country

6.4.1 North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2017-2022)

6.4.2 North America Hospital-Acquired Pneumonia Prevention Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Hospital-Acquired Pneumonia Prevention Market Size (2017-2028)

7.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type

7.2.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2017-2022)

7.2.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Type (2023-2028)

7.2.3 Europe Hospital-Acquired Pneumonia Prevention Market Share by Type (2017-2028)

7.3 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application

7.3.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2017-2022)

7.3.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Application (2023-2028)

7.3.3 Europe Hospital-Acquired Pneumonia Prevention Market Share by Application (2017-2028)

7.4 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country

7.4.1 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2017-2022)

7.4.2 Europe Hospital-Acquired Pneumonia Prevention Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size (2017-2028)

8.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type

8.2.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Share by Type (2017-2028)

8.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application

8.3.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Share by Application (2017-2028)

8.4 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region

8.4.1 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Hospital-Acquired Pneumonia Prevention Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size (2017-2028)

9.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type

9.2.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2017-2022)

9.2.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Type (2023-2028)

9.2.3 Latin America Hospital-Acquired Pneumonia Prevention Market Share by Type (2017-2028)

9.3 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application

9.3.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2017-2022)

9.3.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Application (2023-2028)

9.3.3 Latin America Hospital-Acquired Pneumonia Prevention Market Share by Application (2017-2028)

9.4 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country

9.4.1 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2017-2022)

9.4.2 Latin America Hospital-Acquired Pneumonia Prevention Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size (2017-2028)

10.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type

10.2.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Share by Type (2017-2028)

10.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application

10.3.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Share by Application (2017-2028)

10.4 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country

10.4.1 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Hospital-Acquired Pneumonia Prevention Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Halyard Health

11.1.1 Halyard Health Company Details

11.1.2 Halyard Health Business Overview

11.1.3 Halyard Health Hospital-Acquired Pneumonia Prevention Introduction

11.1.4 Halyard Health Revenue in Hospital-Acquired Pneumonia Prevention Business (2017-2022)

11.1.5 Halyard Health Recent Developments

11.2 Sage Products LLC

11.2.1 Sage Products LLC Company Details

11.2.2 Sage Products LLC Business Overview

11.2.3 Sage Products LLC Hospital-Acquired Pneumonia Prevention Introduction

11.2.4 Sage Products LLC Revenue in Hospital-Acquired Pneumonia Prevention Business (2017-2022)

11.2.5 Sage Products LLC Recent Developments

11.3 Intersurgical Ltd.

11.3.1 Intersurgical Ltd. Company Details

11.3.2 Intersurgical Ltd. Business Overview

11.3.3 Intersurgical Ltd. Hospital-Acquired Pneumonia Prevention Introduction

11.3.4 Intersurgical Ltd. Revenue in Hospital-Acquired Pneumonia Prevention Business (2017-2022)

11.3.5 Intersurgical Ltd. Recent Developments

11.4 Medline Industries

11.4.1 Medline Industries Company Details

11.4.2 Medline Industries Business Overview

11.4.3 Medline Industries Hospital-Acquired Pneumonia Prevention Introduction

11.4.4 Medline Industries Revenue in Hospital-Acquired Pneumonia Prevention Business (2017-2022)

11.4.5 Medline Industries Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Delivery Format : EXCEL/Data Pack

Choose License Type

Checkout Inquiry Sample